Lightstone Ventures
Lightstone Ventures is a leading global venture capital firm.
Business Model:
Revenue: $14.6M
Employees: 51-200
Rankings
Detailed Lightstone Ventures Information
Geographic Data
Address: 485 Ramona St
City: Palo Alto
State: CA
Zip: 94301
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$847M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.
Contact Phone:
+16503883676
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2019 | Locanabio | Series A | 55M |
| 10/2017 | Claret Medical | Series C | 0 |
| 4/2014 | Earlens | Series B | 40M |
| 10/2017 | Gemini Therapeutics | Series A | 42.5M |
| 3/2023 | Relievant Medsystems | Series G | 0 |
| 2/2016 | Cala Health | Series B | 0 |
| 9/2020 | Willow | Series C | 0 |
| 4/2016 | FIRE1 | Series B | 7.5M |
| 3/2017 | ALX Oncology | Convertible Note | 25M |
| 9/2019 | Bold Penguin | Series B | 32M |
| 6/2018 | Relievant Medsystems | Series E | 58M |
| 3/2015 | Nimbus Apollo | Series B | 43M |
| 4/2020 | Cerevance | Series B | 65M |
| 4/2021 | WayCool | Series C | 0 |
| 1/2021 | Ligature Therapeutics | Seed Round | 0 |
| 3/2016 | Tizona Therapeutics | Series B | 43M |
| 10/2016 | Carrick Therapeutics | Series A | 95M |
| 3/2023 | Shoulder Innovations | Series D | 0 |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 65M |
| 1/2023 | Volta Medical | Series B | 0 |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 0 |
| 3/2018 | Cyteir Therapeutics | Series B | 29M |
| 2/2019 | Nuvaira | Equity | 79M |
| 12/2021 | Choiceform | Venture Round | 30M |
| 9/2017 | Disarm Therapeutics | Series A | 30M |
| 5/2017 | Cerevance | Series A | 5M |
| 12/2020 | Locanabio | Series B | 0 |
| 11/2013 | Astria Therapeutics | Series B | 32.4M |
| 10/2018 | Earlens | Series D | 0 |
| 1/2019 | Allay Therapeutics | Series B | 25M |
| 8/2014 | Claret Medical | Series B | 0 |
| 2/2020 | ALX Oncology | Series C | 105M |
| 4/2016 | Gemini Therapeutics | Seed Round | 2M |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 9/2022 | Nimbus Therapeutics | Venture Round | 0 |
| 3/2023 | FIRE1 | Venture Round | 0 |
| 3/2015 | ALX Oncology | Series A | 36M |
| 12/2020 | Tallac Therapeutics | Series A | 62M |
| 1/2014 | FIRE1 | Series A | - |
| 11/2020 | Shoulder Innovations | Venture Round | 0 |
| 2/2023 | Cerevance | Series B | 0 |
| 10/2015 | Elcelyx Therapeutics | Series E | 0 |
| 12/2016 | Cerevance | Series A | 21.5M |
| 12/2019 | Willow | Series C | 20M |
| 10/2020 | Relievant Medsystems | Venture Round | 0 |
| 6/2017 | Earlens | Series C | 0 |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 2/2021 | Cyteir Therapeutics | Series C | 0 |
| 6/2018 | Nimbus Therapeutics | Series B | 65M |
| 11/2020 | Catamaran Bio | Series A | 0 |
| 5/2019 | Cala Health | Series C | 0 |
| 5/2018 | Medisix Therapeutics | Series A | 20M |
| 1/2022 | ProVerum Medical | Series A | 0 |
| 6/2016 | Earlens | Series C | 0 |
| 9/2014 | Flex Pharma | Venture Round | 0 |
| 4/2021 | Alchemab Therapeutics | Series A | 82.7M |
| 1/2018 | FIRE1 | Series C | 49.6M |
| 12/2022 | Carrick Therapeutics | Series C | 0 |
| 3/2015 | Nimbus Therapeutics | Series B | 43M |
| 10/2019 | Cyteir Therapeutics | Series B | 40.2M |
| 1/2017 | Allay Therapeutics | Series A | 7M |
| 7/2015 | Ra Pharmaceuticals | Series B | 58.5M |
| 1/2022 | ProVerum Medical | Series A | 0 |
| 12/2021 | Choiceform | Venture Round | 0 |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 4/2021 | Alchemab Therapeutics | Series A | 0 |
| 4/2021 | WayCool | Series C | 0 |
| 2/2021 | Cyteir Therapeutics | Series C | 0 |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 1/2021 | Ligature Therapeutics | Seed Round | 0 |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 12/2020 | Locanabio | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
